Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome

Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu, Michael A Vogelbaum, Lilyana Angelov; Manmeet Ahluwalia

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome

Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu, Michael A Vogelbaum, Lilyana Angelov, Manmeet Ahluwalia

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Neurosurgery
Volume	129
State	Published - Jul 2018

Disciplines

Medicine and Health Sciences

Cite this

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome. / Michael A Vogelbaum, Lilyana Angelov, Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu,; Ahluwalia, Manmeet.
In: Journal of Neurosurgery, Vol. 129, 07.2018.

Research output: Contribution to journal › Article › peer-review

Michael A Vogelbaum, Lilyana Angelov, Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu, ; Ahluwalia, Manmeet. / Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome. In: Journal of Neurosurgery. 2018 ; Vol. 129.

@article{c38ec1b9495f411d95fb3bedf8ba0464,

title = "Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome",

author = "\{Michael A Vogelbaum, Lilyana Angelov\}, \{Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu,\} and Manmeet Ahluwalia",

note = "OBJECTIVE The goal of this study was to investigate the impact of stereotactic radiosurgery (SRS), BRAF status, and targeted and immune-based therapies on the recurrence patterns and factors associated with overall survival (OS) among patients with melanoma brain metastasis (MBM). METHODS A total of ...",

year = "2018",

month = jul,

language = "American English",

volume = "129",

journal = "Journal of Neurosurgery",

}

TY - JOUR

T1 - Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome

AU - Michael A Vogelbaum, Lilyana Angelov, Rupesh Kotecha, Jacob A Miller, Vyshak A Venur, Alireza M Mohammadi, Samuel T Chao, John H Suh, Gene H Barnett, Erin S Murphy, Pauline Funchain, Jennifer S Yu,

AU - Ahluwalia, Manmeet

N1 - OBJECTIVE The goal of this study was to investigate the impact of stereotactic radiosurgery (SRS), BRAF status, and targeted and immune-based therapies on the recurrence patterns and factors associated with overall survival (OS) among patients with melanoma brain metastasis (MBM). METHODS A total of ...

PY - 2018/7

Y1 - 2018/7

UR - https://pubmed.ncbi.nlm.nih.gov/28799876/

M3 - Article

VL - 129

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

ER -

Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome

Disciplines

Other files and links

Cite this